Stockreport

Press Release: Sanofi’s Qfitlia and Cablivi approved in China, expanding care for rare diseases

Sanofi - American Depositary Shares  (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
PDF Sanofi’s Qfitlia and Cablivi approved in China, expanding care for rare diseases Qfitlia, the first antithrombin-lowering therapy for hemophilia, can offer consistent p [Read more]